pulmonale in pulmonary sarcoidosis. Right-heart overload happens relatively rarely in sarcoidosis, even with fibroemphysematous changes. Of 21 cases that we studied, six (28%) had clinical and/or electrocardiographic features of cor pulmonale. The cause of cor pulmonale often evoked is an invasion of the walls of pulmonary vessels by sarcoid granulomas or their compression by the fibrotic process. Pathological studies in one patient showed compression of large pulmonary arteries associated with specific sarcoid lesions in small and medium-sized arteries.
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The development of chronic cor pulmonale due to pulmonary hypertension has rarely been described in pulmonary sarcoidosis, even in chronic fibroemphysematous forms. The mechanisms often evoked to explain the occurrence of pulmonary hypertension are based on histological findings, the perivascular occurrence of granulomas with the fibrosis which sometimes results, and the possibility of thrombosis or invasion of arterial and vein walls by granulomas.
Material and methods
Twenty-one cases of chronic sarcoidosis were studied.
The diagnosis was made using clinical, radiological, pathological (bronchial biopsy), and immunological (Kveim test, tuberculin anergy) findings. Such a diagnosis was confirmed in life by these methods even in the two cases (2 and 5) where no definite evidence of sarcoidosis was found at necropsy many years later.
The radiographic classification was based on postero-anterior and lateral views, occasionally confirmed by tomography.
Evidence of right-sided heart involvement was based upon clinical examination and six electrocardiographic criteria (Schaub, 1966 (Fig. 3) .
In all patients, the radiographic abnormalities remained unchanged for several years in spite of 76 (Table) .
Worsening of her dyspnoea and the rapid onset of clinical heart failure suggested pulmonary embolism. Angiography (Fig. 4 pulmonary sarcoidosis. Among 13 patients who died from sarcoid pulmonary fibrosis, Scadding (1967) observed three with clinical right ventricular failure and one with isolated electrocardiographic right ventricular hypertrophy, thus finding evidence of chronic cor pulmonale in 30% of cases. According to this author, the association with chronic bronchitis is an important aetiological factor. Out of 11 necropsies of sarcoid fibrosis, Sones and Israel (1960) observed four cases of chronic cor pulmonale (36%); Mayock et al. (1963) noted three cases out of nine deaths. In our group, chronic cor pulmonale manifestations with or without right heart failure were observed in six out of 21 cases (28 6%).
Studies of the pathology of pulmonary hypertension in sarcoidosis have shown in the majority of cases only the small and medium-sized arteries to be clearly affected. Lesions consist of generally incomplete thrombosis provoked by either peribronchovascular fibrosis or granulomatous invasion of the vascular walls (Mallory, 1948; Longcope and Freiman, 1952; Thompson, 1966; Turiaf et al., 1973) . Thromboembolism may be superimposed in some cases. On the other hand, involvement of the large branches of the pulmonary artery is exceptional. Schermuly and Behrend (1968) performed pulmonary angiography on 150 subjects suffering from sarcoidosis and observed modifications in the orientation of the proximal arteries. These modifications were attributed to the fibrosis, but no change in size of the pulmonary vessels provoked by lymph-node compression was noted. The authors did not specify the stage of evolution of the illness (in particular, the presence or absence of mediastinal adenopathies). Shibel et al. (1969) studied 31 subjects suffering from sarcoidosis and noticed abnormalities in peripheral perfusion detected by scintigraphy in two cases where isolated mediastinal adenopathy was present. The authors postulated either the existence of pulmonary impairment undetected by radiography or a decrease in the diameter of the proximal vessels. Westcott and de Graff (1973) reported the case of a 29-year-old coloured man with mediastinal lymph adenopathy. Scintigraphy revealed a perfusion defect of the upper right lobe, suggesting pulmonary embolism. A right pulmonary arteriogram showed compression of the right upper lobe artery by hilar nodes. Eleven months later, the chest radiograph and scintigraphy spontaneously returned to normal. Gordonson et al. (1973) 
Comment
Airways obstruction was strikingly relieved by aspirin in the patient studied. Similar beneficial effects were produced by three other cyclooxygenase inhibitors, that is, by indomethacin, mefenamate, and fenoprofen, but not by two remaining analgesics-salicylamide and benzydamine-which do not inhibit PG biosynthesis (Vane, 1976; Szczeklik et al, 1977) . It was, therefore, logical to assume that the pharmacological removal of a product of arachidonic acid (AA) cyclooxygenation from his respiratory tract helped our patient to overcome the airways obstruction. Perhaps this product was a bronchoconstrictor PGF2a, TXA2, or other as yet unknown metabolite. Whatever the metabolite was, it could not have been a physiological one, since we have found that bronchodilator PGI2 and PGE2 are two major products of AA transformation in the lungs .
In our patient the suspected abnormality in arachidonate metabolism was restricted to the respiratory system. Detailed platelet function studies, particularly those related to arachidonic pathway, failed to show any differences from the normal. The transient petechiae were most likely due to increased vascular fragility secondary to triamcinolone administration.
The number of asthmatic patients who might benefit from aspirin is not known. Trial of aspirin treatment might seem warranted in asthma, since it could allow the steroid dose to be reduced, as in our case. Great care, however, would be necessary at the beginning of such treatment, and the initial dose of aspirin should not exceed 20-40 mg, as the same cyclo-oxygenase inhibitors, which proved to be so efficient in relieving bronchoconstriction in our patient, may produce bronchoconstriction in other asthmatics suffering from socalled aspirin-induced asthma (Szczeklik et al, 1975; 1977) . Thus two opposite reactions can be caused in asthmatics by the same specific inhibitors. This indicates that different mediators, even derived from the same precursor, might play a different role in various types of asthma.
Discussion

